PII

The key to our success is being able to provide a flexible approach for the client

Join our Mailing List

Your Email

Formulation Development

Pii has a broad knowledge and technical experience in dosage form development and cGMP manufacturing

labworkers Pii is able to provide clients with a wide range of options to develop small molecules into quality pharmaceutical products.  The key to our success is being able to provide a flexible approach for the client whether it is a step-by-step approach to development work or simply the transfer of a product into development at late stage.  Pii’s highly trained scientific team has extensive experience working with a variety of drug substances with a range of physicochemical characteristics, including:

  • Poorly aqueous soluble drugs
  • Highly potent and cytotoxic drugs

From first in man studies to commercial launch, Pii will thoughtfully work with you to determine the most efficient and viable pathway for your compound.  Pii’s development capabilities include modified and extended release formulations.  For poorly soluble compounds, Pii offers a variety of bioavailability enhancement technologies, including solid dispersion development and lipid-or macro/nano-based emulsions.

Dosage Forms

  • Conventional tablets
  • Conventional capsules
  • Controlled/delayed release tablets and capsules
  • Hard gelatin/HPMC liquid filled capsules
  • API in a capsule
  • Softgels
  • Hot melt extrusion
  • Spray drying
  • Powder for reconstitution
  • Micronization/nanoparticles/microfluidization
  • Amorphous solid solutions
  • Liquid formulations
  • Inhalation (DPI, MDI, & nasal sprays)
  • Ointments/creams/gels
  • Suspensions/syrups/solutions
  • Sterile injectable products
  • Freeze-dried products
  • Coated beads, tablets and capsules

 

© Copyright 2017 Pharmaceutics International, Inc. | Privacy Policy | Terms & Conditions